MT-802 is a potent BTK degrader based on Cereblon ligand, with a DC 50 of 1 nM. MT-802 has potential to treat C481S mutant chronic lymphocytic leukemia (CLL).
性状
Solid
IC50 & Target[1][2]
DC50: 1 nM (BTK).
体外研究(In Vitro)
MT-802 degrades BTK with a DC50 of 9.1 nM with maximal degradation being observed by 250 nM. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Buhimschi AD, et al. Targeting the C481S Ibrutinib-Resistance Mutation in Brutons Tyrosine Kinase Using PROTAC-Mediated Degradation. Biochemistry. 2018 Jul 3;57(26):3564-3575.
溶解度数据
In Vitro: DMSO : 100 mg/mL (126.93 mM; Need ultrasonic)配制储备液